Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01416051 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Olibra: A 12 Week Controlled Trial
A Phase 1 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 82
- Enrollment target
NCT01416051 is a Phase 1 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 82 participants.
The verdict
NCT01416051, a Phase 1 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 82 participants
- Enrollment target
Study Summary
Today's obesogenic environment, favors behavioral choices that lead to an excess of energy intake over expenditure, and consequently weight gain. Intervention strategies that harness the body's own appetite and satiety regulating signals could provide an effective means of countering excessive energy intake. The purpose of this study was to investigate whether a vegetable oil emulsion (Olibra) would result in weight loss that was associated with a reduction in food intake.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Olibra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2005-01 |
| Est. Completion | 2006-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01416051
The ClinicalTrials.gov registry entry for NCT01416051 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01416051 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01416051 about?
NCT01416051 is a clinical study titled "Efficacy of Olibra: A 12 Week Controlled Trial". Today's obesogenic environment, favors behavioral choices that lead to an excess of energy intake over expenditure, and consequently weight gain. Intervention strategies that harness the body's own appetite and satiety regulating signals could provide an effective means of countering excessive energ...
What is the current status of trial NCT01416051?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 82 participants. The study started on 2005-01. Estimated completion is 2006-11.
What interventions are being tested in trial NCT01416051?
The interventions under investigation include: Placebo (OTHER), Olibra (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01416051?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.